The standard CDMO business model, which charges for fermentation time, rewards maximizing equipment utilization rather than process innovation. This creates a misalignment with clients who want faster, more efficient processes. An alternative model aligns CDMO revenue with process improvements, not process duration.

While AI expands software's capabilities, vendors may not capture the value. Companies could use AI to build solutions in-house more cheaply. Furthermore, traditional "per-seat" pricing models are undermined when AI reduces the number of employees required, potentially shrinking revenue even as the software delivers more value.

As agencies adopt AI to increase efficiency, clients will rightfully question traditional pricing models based on billable hours. This creates an "arbitrage" problem, forcing agencies to redefine and justify their value based on strategic insight and outcomes, not just the labor involved.

AI requires significant upfront investment with uncertain returns, creating an "investment paradox" for CFOs. Traditional ROI models are insufficient. A new financial framework is needed that measures not just cost savings but also revenue acceleration, risk mitigation, and the strategic option value of competitive positioning.

Professional services firms on a billable hour model face an existential threat from AI. As AI compresses work from hours to minutes, clients will demand savings, forcing firms to transition to defensible, value-based pricing models or risk obsolescence.

AI tools drastically reduce the time needed to complete complex tasks, breaking the traditional billable-hour model for consultants and agencies. The focus must shift to value-based pricing, where compensation is tied to the problem solved or the output created, not the hours worked.

The $15-$25 per-review price for Anthropic's tool moves AI expenses from a predictable monthly software subscription to a variable cost that scales like human labor. This forces CTOs to justify AI budgets with direct headcount savings, creating immense pressure on ROI.

VC Keith Rabois highlights a core conflict: law firms billing by the hour are disincentivized from adopting AI that makes associates more efficient, as it reduces revenue. This explains why corporate legal departments are faster adopters—their goal is to cut costs.

A traditional IT investment ROI model misses the true value of AI in pharma. A proper methodology must account for operational efficiencies (e.g., time saved in clinical trials, where each day costs millions) and intangible benefits like improved data quality, competitive advantage, and institutional learning.